IL13RA2 and central nervous system cancer: In patients with worse prognosis, the expression of these antigens was found more severe and could be possibly explained by certain hypothesis such as, glioma cells adopt overexpression of IL13Rα2 that protect it from immunosuppression (Barderas et al., 2012; Han & Puri, 2018).